Back to mobile site

AVEO Oncology (AVEO) Announces Restructuring; Will Explore Ficlatuzumab Development Via Collaboration

October 30, 2012 6:32 AM EDT Send to a Friend
AVEO Oncology (NASDAQ: AVEO) announced a strategic restructuring designed to optimize resources and reduce expenses to ensure AVEO is well ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login